Oral and intravenous D-ribose and plasma insulin in healthy humans: effects of route of administration and of epinephrine and propranolol.
D000284:Administration, Oral; D000328:Adult; D001786:Blood Glucose / Q000032:analysis; D004336:Drug Antagonism; D004837:Epinephrine / Q000494:pharmacology*; D005215:Fasting; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D007328:Insulin / Q000097:blood* / Q000378:metabolism; D000078790:Insulin Secretion; D008099:Liver / Q000378:metabolism; D008297:Male; D010179:Pancreas / Q000378:metabolism; D011433:Propranolol / Q000494:pharmacology*; D012266:Ribose / Q000008:administration & dosage* / Q000097:blood
D001786:Blood Glucose; D007328:Insulin; D012266:Ribose; D011433:Propranolol; D004837:Epinephrine